Skip to main content
. 2020 Nov 16;12(11):3386. doi: 10.3390/cancers12113386

Table 4.

Therapeutic and diagnostic application of EVs in a treatment attempt.

Modality EVs Origin Type of Contrast Media Therapeutic Mechanism/Application Reference
Magnetic resonance imaging Cancer cell lines (4T1, HepG2, and SKBR3) Gold–iron oxide nanoparticles Anti-miR-21. Phototherapy treatment. Bose, R.J.C., ACS Nano, 2018 [97]
Magnetic resonance imaging MDA-MB-231 human breast cancer cells Superparamagnetic iron oxide nanoparticles Olaparib (PARP inhibitor) Jung, K.O., Biomaterials, 2018 [104]
Magnetic resonance imaging Macrophage cells Iron oxide nanoparticles Chemotherapeutic agent (doxorubicin), tissue plasminogen activator (t-PA) and two photosensitizers Silva, A.K., Nanomedicine, 2015 [101]
Magnetic resonance imaging Lung fibroblast cell Super paramagnetic iron oxide nanoparticle Anticancer drug (doxorubicin) Srivastava, A., Sci. Rep., 2016 [103]
Magnetic resonance imaging Macrophage cell line Raw264.7 Superparamagnetic iron oxide nanoparticles Curcumin (Cur) and neuropilin-1-targeted peptide Jia, G., Biomaterials, 2018 [102]